In the last trading session, 1.82 million Myriad Genetics, Inc (NASDAQ:MYGN) shares changed hands as the company’s beta touched 1.81. With the company’s per share price at $4.45 changed hands at $0.02 or 0.45% during last session, the market valuation stood at $410.19M. MYGN’s last price was a discount, traded about -558.43% off its 52-week high of $29.30. The share price had its 52-week low at $3.81, which suggests the last value was 14.38% up since then.
Analysts gave the Myriad Genetics, Inc (MYGN) stock a consensus recommendation rating of Hold, calculated at a mean rating of 3.00. If we narrow down to specifics, the data shows that 0 out of 7 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 5 recommended MYGN as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight.
Myriad Genetics, Inc (NASDAQ:MYGN) trade information
Instantly MYGN was in green as seen at the end of in last trading. With action 8.27%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -67.54%, with the 5-day performance at 8.27% in the green. However, in the 30-day time frame, Myriad Genetics, Inc (NASDAQ:MYGN) is -39.86% down.
The consensus price target for the stock as assigned by Wall Street analysts is 12.5, meaning bulls need an upside of 64.4% from its current market value. According to analyst projections, MYGN’s forecast low is 6 with 21 as the target high. To hit the forecast high, the stock’s price needs a -371.91% plunge from its current level, while the stock would need to soar -34.83% for it to hit the projected low.
The 2025 estimates are for Myriad Genetics, Inc earnings to decrease by -106.15%, but the outlook for the next 5-year period is at 26.55% per year.
MYGN Dividends
Myriad Genetics, Inc is expected to release its next quarterly earnings report in June.
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 11.1089% or 10.06 million shares worth $246.18 million as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were iShares Trust-iShares Core S&P Small-Cap ETF and VANGUARD EXPLORER FUND . With 5.63 shares estimated at $25.05 million under it, the former controlled 6.11% of total outstanding shares. On the other hand, VANGUARD EXPLORER FUND held about 3.57% of the shares, roughly 3.29 shares worth around $14.66 million.
